Javascript must be enabled to continue!
Influence of ZAP-70 Expression On Migration of Chronic Lymphocytic Leukemia (CLL) and Lymphoma Cells.
View through CrossRef
Abstract
Abstract 2345
Poster Board II-322
ZAP-70 (ξ-associated protein) is a tyrosine kinase (PTK) of the Syk/ZAP family normally expressed in T and NK cells. Increased ZAP-70 expression in CLL correlates with unmutated IgVH genes, a short time of progression, and a short survival. Mechanisms by which increased ZAP-70 protein expression can influence clinical outcome are not fully understood. After B-cell receptor (BCR) stimulation, activated ZAP-70 can cooperate with Syk, the tyrosine kinase of the BCR signal pathway normally expressed in B-cells, thus inducing activation of the CLL cells. Stimulation of the BCR leads to the triggering of Syk protein kinase to the cytoplasmatic tails of the receptor initiating subsequent activation of critical effector enzymes such as PI3K and PLCγ2. The PI3K/Akt pathway is related to survival and protection from BCR-induced apoptosi. Against this background, we analyzed the functional consequences of abnormal expression of ZAP-70 protein in B-lymphoma cell lines that normally does not express ZAP-70, particularly analyzing the impact of increased ZAP-70 expression oncell metabolism and cell migration. Mec-1 (CLL), Raji and Ramos (Burkitt) cell lines were stably transfected with the ZAP-70 expression vector pEGFP-ZAP-70 as well as the control pEGFP. BCR stimulation was induced in the stable Ramos cell line by IgM at several time points, and phosphorylation of downstream proteins was analyzed by Western Blot. Proliferation, cell cycle, calcium flux, adhesion molecules and cell migration were analyzed in all stable cell lines after ZAP-70 phosphorylation. After IgM stimulation, in Ramos cell line phosphorylation of ZAP-70 was observed at residue Y319 and, simultaneously, phospho-Syk expression was reduced. In addition, Erk protein was strongly activated in ZAP-70 transfected cell line compared to the control cell line, this activation lasting more than 24 hours. Notably, calcium flux detected by flow cytometry was higher in ZAP-70 transfected Ramos. Migration experiments showed that after IgM stimulation, transfected ZAP-70 Ramos migrated significantly more rapidly than cells transfected with the vector alone. Of note, after IgM stimulation, ZAP-70 transfected Ramos cells expressed a higher number of adhesion molecules (CXCR7 and others) on surface membrane than non-transfected cells. This effect on migration stimulation was also observed with the Raji cell line transfected with ZAP-70. In conclusion, addition of ZAP-70 expression to a heterologous B-cell system enhances BCR downstream signalling, calcium mobilization, and migration. Ongoing studies are determining the influence on the gene expression profile dependent of ZAP-70 expression. Altogheter, these data suggest that additional ZAP-70 expression in CLL and other lymphoproliferative disorders enhances tumoral activity, this explaining in part the poor clinical prognosis of patients with increased expression of ZAP-70.
Disclosures:
No relevant conflicts of interest to declare.
American Society of Hematology
Title: Influence of ZAP-70 Expression On Migration of Chronic Lymphocytic Leukemia (CLL) and Lymphoma Cells.
Description:
Abstract
Abstract 2345
Poster Board II-322
ZAP-70 (ξ-associated protein) is a tyrosine kinase (PTK) of the Syk/ZAP family normally expressed in T and NK cells.
Increased ZAP-70 expression in CLL correlates with unmutated IgVH genes, a short time of progression, and a short survival.
Mechanisms by which increased ZAP-70 protein expression can influence clinical outcome are not fully understood.
After B-cell receptor (BCR) stimulation, activated ZAP-70 can cooperate with Syk, the tyrosine kinase of the BCR signal pathway normally expressed in B-cells, thus inducing activation of the CLL cells.
Stimulation of the BCR leads to the triggering of Syk protein kinase to the cytoplasmatic tails of the receptor initiating subsequent activation of critical effector enzymes such as PI3K and PLCγ2.
The PI3K/Akt pathway is related to survival and protection from BCR-induced apoptosi.
Against this background, we analyzed the functional consequences of abnormal expression of ZAP-70 protein in B-lymphoma cell lines that normally does not express ZAP-70, particularly analyzing the impact of increased ZAP-70 expression oncell metabolism and cell migration.
Mec-1 (CLL), Raji and Ramos (Burkitt) cell lines were stably transfected with the ZAP-70 expression vector pEGFP-ZAP-70 as well as the control pEGFP.
BCR stimulation was induced in the stable Ramos cell line by IgM at several time points, and phosphorylation of downstream proteins was analyzed by Western Blot.
Proliferation, cell cycle, calcium flux, adhesion molecules and cell migration were analyzed in all stable cell lines after ZAP-70 phosphorylation.
After IgM stimulation, in Ramos cell line phosphorylation of ZAP-70 was observed at residue Y319 and, simultaneously, phospho-Syk expression was reduced.
In addition, Erk protein was strongly activated in ZAP-70 transfected cell line compared to the control cell line, this activation lasting more than 24 hours.
Notably, calcium flux detected by flow cytometry was higher in ZAP-70 transfected Ramos.
Migration experiments showed that after IgM stimulation, transfected ZAP-70 Ramos migrated significantly more rapidly than cells transfected with the vector alone.
Of note, after IgM stimulation, ZAP-70 transfected Ramos cells expressed a higher number of adhesion molecules (CXCR7 and others) on surface membrane than non-transfected cells.
This effect on migration stimulation was also observed with the Raji cell line transfected with ZAP-70.
In conclusion, addition of ZAP-70 expression to a heterologous B-cell system enhances BCR downstream signalling, calcium mobilization, and migration.
Ongoing studies are determining the influence on the gene expression profile dependent of ZAP-70 expression.
Altogheter, these data suggest that additional ZAP-70 expression in CLL and other lymphoproliferative disorders enhances tumoral activity, this explaining in part the poor clinical prognosis of patients with increased expression of ZAP-70.
Disclosures:
No relevant conflicts of interest to declare.
Related Results
Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Abstract
Abstract 3607
Background:
In B-cell chronic lymphocytic leukemia (B-CLL) there is a well documented intr...
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction:
The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
Combined Therapy of Zanubrutinib and Zilovertamab in the Inhibition of Invasive Capability of Chronic Lymphocytic Leukemia Cells
Combined Therapy of Zanubrutinib and Zilovertamab in the Inhibition of Invasive Capability of Chronic Lymphocytic Leukemia Cells
Signaling pathways such as CXCR4/CXCL12 can regulate migration and trafficking of chronic lymphocytic leukemia (CLL) cells from the blood to lymphoid tissues, where they receive gr...
Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL).
Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL).
Abstract
Abstract 667
Historically CLL has been considered a non-proliferative disease characterized by accumulation of leukemic cells. However, recen...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Incidence Of Atypical Chronic Lymphocytic Leukemia In 1819 Patients With B Chronic Lymphoproliferative Disorder
Incidence Of Atypical Chronic Lymphocytic Leukemia In 1819 Patients With B Chronic Lymphoproliferative Disorder
Abstract
Flow cytometry is the diagnostic tool of choice to study abnormal lymphoid population detected in peripheral blood by morphological analysis. The main diagn...
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Abstract
Background CD8+ T cells from chronic lymphocytic leukemia (CLL) patients have been demonstrated to exhibit a number of alterations in global gene expression...
Impact of Atrial Fibrillation on Cardiovascular and Economic Outcomes in Patients with Chronic Lymphocytic Leukemia
Impact of Atrial Fibrillation on Cardiovascular and Economic Outcomes in Patients with Chronic Lymphocytic Leukemia
Abstract
Introduction: Chronic lymphocytic leukemia (CLL) is the most frequently diagnosed hematologic cancer, with many patients diagnosed at a later stage in life ...

